SPI1 and neoplasm: In addition, although current studies have obtained useful findings, more laboratory studies both in vitro and in vivo are needed to validate these bioinformatic results in the future, such as the levels of SPI1-TYROBP-FCER1G network-regulated immune molecules in OS tumor cells.